pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    flixebrutinib
    flixebrutinib
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Telios Pharma Inc
  • Phase 2
    flucytosine ER + vocimagene amiretrorepvec
    flucytosine + vocimagene amiretrorepvec
    Glioblastoma Multiforme (GBM) Denovo Biopharma LLC
  • Phase 2
    foscenvivint
    foscenvivint [INN]
    Colorectal Cancer Eisai Co Ltd
  • Phase 2
← prev
page 15 of 21
next →
131
Pain89
Neurology1
fosdesdenosine sipalabenamide
fosdesdenosine sipalabenamide [INN]
Metastatic Melanoma
$NCNA NuCana plc
  • Phase 2
    fostroxacitabine bralpamide hydrochloride
    fostroxacitabine bralpamide hydrochloride
    Hepatocellular Carcinoma Medivir AB
  • Phase 2
    fulzerasib
    fulzerasib [INN]
    Metastatic Colorectal Cancer GenFleet Therapeutics (Shanghai) Inc
  • Phase 2
    garetatug rezetecan
    garetatug rezetecan [INN]
    Gastric Cancer Jiangsu Hengrui Pharmaceuticals Co Ltd
  • Phase 2
    gedeptin
    Nasopharyngeal Cancer$GOVX GeoVax Labs, Inc.
  • Phase 2
    gemogenovatucel-T
    Vigil (gemogenovatucel-T)
    Endometrial Cancer Gradalis Inc
  • Phase 2
    glecirasib
    glecirasib [INN]
    Non-Small Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd
  • Phase 2
    gocatamig
    gocatamig
    Small-Cell Lung Cancer$MRK Merck & Co., Inc.
  • Phase 2
    golidocitinib
    golidocitinib
    Peripheral T-Cell Lymphomas (PTCL) Dizal Pharmaceutical Co Ltd
  • Phase 2
    guadecitabine sodium
    guadecitabine sodium
    Fallopian Tube Cancer Astex Pharmaceuticals Inc
  • Phase 2
    gumarontinib
    gumarontinib [INN]
    Non-Small Cell Lung Cancer Shanghai Haihe Biopharma Co Ltd
  • Phase 2
    huMNC2-CAR22
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Minerva Biotechnologies Corp
  • Phase 2
    huMNC2-CAR44
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Minerva Biotechnologies Corp
  • Phase 2
    hydroxyprogesterone caproate
    Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])
    Premature Labor (Tocolysis)$LPCN Lipocine Inc.
  • Phase 2
    iadademstat
    iadademstat [INN]
    Small-Cell Lung Cancer Oryzon Genomics SA
  • Phase 2
    ibcasertib
    ibcasertib [INN]
    Breast Cancer Shenzhen Chipscreen Biosciences Co Ltd
  • Phase 2
    idroxioleic acid
    idroxioleic acid
    Malignant Glioma Laminar Pharmaceuticals SA
  • Phase 2
    imifoplatin
    imifoplatin
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Promontory Therapeutics Inc
  • Phase 2
    imneskibart
    imneskibart
    Colorectal Cancer Aulos Bioscience Inc
  • Phase 2
    imzokitug
    imzokitug
    Colorectal Cancer Bristol-Myers Squibb Co
  • Phase 2
    inlexisertib
    inlexisertib
    Gastrointestinal Stromal Tumor (GIST) Deciphera Pharmaceuticals Inc
  • Phase 2
    inobrodib
    inobrodib
    Refractory Multiple Myeloma CellCentric Ltd
  • Phase 2
    intismeran autogene
    intismeran autogene
    Metastatic Melanoma$MRNA Moderna, Inc.
  • Phase 2
    invikafusp alfa
    invikafusp alfa [INN]
    Triple-Negative Breast Cancer (TNBC) Marengo Therapeutics Inc
  • Phase 2
    iobenguane I 131
    iobenguane I 131
    Neuroblastoma Jubilant DraxImage Inc
  • Phase 2
    iodofalan I 131
    iodofalan I 131
    Recurrent Glioblastoma Multiforme (GBM)$TLX Telix Pharmaceuticals Ltd
  • Phase 2
    iopofosine i-131
    iopofosine i-131
    Multiple Myeloma (Kahler Disease)$CLRB Cellectar Biosciences, Inc.